Active	Status	Sponsor type	Region	Phase	Filter
28 Active 13 Inactive 41 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhang, Zhen
ESPRESSO, NCT04641819: Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients	Active, not recruiting	4	1127	RoW	Yangzheng Compound Mixture, Z10970042（NMPA Approval Number）, Conventional Treatment	ShuGuang Hospital, LinkDoc Technology (Beijing) Co. Ltd., Shaanxi Buchang Pharmaceutical Co., Ltd	Carcinoma, Sleep Disorder	09/23	06/24
NCT05439629: Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration	Active, not recruiting	3	488	RoW	BAT5906 injection, Lucentis	Bio-Thera Solutions	Neovascular (Wet) Age-related Macular Degeneration	04/24	06/25
TQB2450-III-13, NCT06475599: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer	Not yet recruiting	3	420	RoW	Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Endometrial Cancer	12/27	06/29
Sun, Wenjie
No trials found